Skip to main content
Caplight Logo









Synergia Medical

Synergia Medical

Private
BrusselsHealthcare & Life Scienceshttps://www.synergia-medical.com/

Last Round

Series B

Extension

Jan 18, 2023

Total Funding Raised

$29.77M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Synergia Medical is a medical device company that develops next-generation, optoelectronic neurostimulation technologies for the treatment of drug-resistant epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurostimulationvagus nerve stimulationVNSimplantable medical deviceAIMDoptoelectronic deviceMRI compatibleepilepsy treatmentneuromodulationbioelectronicsactive implantelectromagnetic interferenceEMImedtechmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synergia Medical Comparables

Compare Synergia Medical with similar companies based on industry and business-model similarity.

Synergia Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cadence Neuroscience
84%
LivaNova
77%
NeuroPace
72%

Synergia Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 18, 2023
GrantOct 19, 2022
Series BSep 12, 2022
AcceleratorJun 22, 2020
Series AFeb 19, 2018

Key People

Founding team and executive leadership

Charles Nolet

Chief Executive Officer

Executive Team

Carole Monterrat

CFO

Executive Team

Dimitri Crelot

Chief Financial Officer

Executive Team

Dan Scherrer

Chief Operating Officer

Executive Team

Synergia Medical Investors

Notable investors and investment history

Synergia Medical investors
InvestorRounds
Federal Holding and Investment CompanySeries A, Series B
European Innovation Council FundGrant
Newton BiocapitalSeries B, Series A
MedTech InnovatorAccelerator
Société Régionale d'Investissement de WallonieSeries A
InvestsudSeries B, Series B Extension
NivelinvestSeries B, Series B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 88% MoM.

  • Feb 1, 2025

    Attila Borbath stepping down, Charles Nolet to succeed him February 1, 2025.

Synergia Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Synergia Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Synergia Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrussels
Employee Range18
Year Founded2015
Last FundingJan 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?